Follow-up of the efficacy of topical CG428 for chemotherapy-induced nail damage in breast cancer patients undergoing adjuvant chemotherapy. - Trial UMIN000048583
Access comprehensive clinical trial information for UMIN000048583 through Pure Global AI's free database. This phase not specified trial is sponsored by Nagasaki Harbor Medical Center and is currently Not yet recruiting. The study focuses on breast cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
UMIN000048583
Not yet recruiting
other
Trial Details
University Hospital Medical Information Network • UMIN000048583
Follow-up of the efficacy of topical CG428 for chemotherapy-induced nail damage in breast cancer patients undergoing adjuvant chemotherapy.
Study Focus
Sponsor & Location
Nagasaki Harbor Medical Center
Japan
Timeline & Enrollment
N/A
Aug 15, 2022
N/A
ICD-10 Classifications
Malignant neoplasm of breast
Malignant neoplasm of breast
Carcinoma in situ of breast, unspecified
Malignant neoplasm: Breast, unspecified
Other carcinoma in situ of breast
Data Source
University Hospital Medical Information Network
UMIN000048583
Non-Device Trial